
See how much monthly passive income you can generate from Novo Nordisk A/S. Calculate dividend growth with DRIP and compound interest using real-time data.

1 Year
15 Years
30 Years
0% (No Growth)
10%
20%
0% (No Growth)
10%
20%
0% (Tax-Advantaged)
20%
40%
DRIP (Dividend Reinvestment Plan) significantly accelerates portfolio growth through compounding.
Based on the current price of $44.74, NVO offers a compelling dividend yield of 4.03%. This is higher than the S&P 500 average.
Historically, Novo Nordisk A/S has raised its payouts by an average of 27% annually over the last 5 years.
With a payout ratio of 20%, the dividend appears safe.
| ETF / Stock | Current Yield | 5Y Dividend Growth | |
|---|---|---|---|
![]() NVO Novo Nordisk A/S | 1.8% | 27% | ACTIVE |
![]() JNJ Johnson & Johnson | 5.36% | 4.9% | Calculate → |
![]() PFE Pfizer Inc | 1.72% | 3.6% | Calculate → |
![]() UNH UnitedHealth Group Incorporated | 8.84% | 9.6% | Calculate → |